Literature DB >> 15478557

[Drug resistance of Mycobacterium tuberculosis of the genotype Beijing in imprisonment places in the Arkhangelsk Region].

O S Tungusova, A O Mar'iandyshev, H Bewne, P Sandwen.   

Abstract

The paper describes the molecular genetic characteristics of M. tuberculosis (MT) strains isolated from 114 patients with pulmonary tuberculosis in the penitentiary system of the Arkhangelsk Region. The sensibility to the first-line antituberculous drugs was determined by the radiometric technique BACTEC; rpoB gene mutations were identified by Inno-Lipa, genotyping was made by the RFLPA assay and spoligotyping. The spread of MT of the genotype Beijing in the penitentiary system was found to be 76.3%. The high rate (79.8%) of the clustering pattern is indicative of active transmission of tuberculosis. The transmission of the Beijing genotype MBT strains was higher (96.6%) than that of other genetypes (25.9%). A multifactorial analysis has shown that streptomycin resistance is independently associated with the infection with the strain of MBT of the genotype Beijing (p = 0.02); the circulation and active transmission of Beijing among the population present a human health threat and an endemic risk from the spread of drug-resistant pulmonary tuberculosis.

Entities:  

Mesh:

Year:  2004        PMID: 15478557

Source DB:  PubMed          Journal:  Probl Tuberk Bolezn Legk        ISSN: 1728-2993


  2 in total

1.  Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries.

Authors:  David Stuckler; Sanjay Basu; Martin McKee; Lawrence King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

2.  Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.

Authors:  I Kontsevaya; S Mironova; V Nikolayevskyy; Y Balabanova; S Mitchell; F Drobniewski
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.